JUN and plasma cell myeloma: Furthermore, Podar et al. demonstrated that Jun upregulation in multiple myeloma inhibited proliferation and induced apoptosis, and that reduced Jun expression demonstrated tendency towards both a reduced overall survival and event-free survival in 11 of 67 multiple myeloma patients [61].